ClinicalTrials.Veeva

Menu

Bolus vs. Continuous IV Lidocaine Against Post-Extubation Cough in Post-Thyroidectomy Patients

U

Universitas Padjadjaran

Status and phase

Completed
Phase 2

Conditions

Cough

Treatments

Drug: Lidocaine IV

Study type

Interventional

Funder types

Other

Identifiers

NCT06040034
AN-202309.01

Details and patient eligibility

About

The goal of this randomized controlled trial is to compare the effect of lidocaine bolus intravenous administration to lidocaine continuous intravenous administration in post thyroidectomy patients to observe the effect against post-extubation cough. The main questions it aims to answer are:

  • Cough incidence on both groups
  • Which method is preferable to reduce post-extubation cough incidence

Enrollment

40 patients

Sex

All

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ASA class 1 and 2
  • Thyroidectomy patients in Hasan Sadikin Bandung Hospital

Exclusion criteria

  • Subjects' refusal
  • Had history of drug allergy, specifically lidaocaine
  • Had history of asthma or other lung diseases
  • Active smoker
  • History of arrhythmia
  • Bradycardia subjects (<60 beats per minute)
  • Pregnant people
  • Perioperative upper respiratory tract infusion
  • Routinely consume ACE inhibitor / bronchodilators / steroid
  • Renal dysfunction
  • Liver dysfunction

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

40 participants in 2 patient groups

Continuous Lidocaine Intravenous Infusion
Active Comparator group
Description:
Patients were given a loading dose of 1.5 mg/kgBW intravenous lidocaine for 10 minutes before induction of anesthesia using a syringe pump, followed by continuous intravenous administration of 1.5 mg/kgBW/hour lidocaine until 30 minutes before the end of the surgery (when the skin is being sutured by the surgeon) using a syringe pump. Continuous administration of lidocaine was prepared by the research team as 10 cc of 20 mg/cc lidocaine in a 10 cc syringe and 10 cc of 0.9% NaCl in a 10 cc syringe.
Treatment:
Drug: Lidocaine IV
Bolus Lidocaine Intravenous
Active Comparator group
Description:
Patients were given a loading dose of 1.5 mg/kgBW intravenous lidocaine for 10 minutes before induction of anesthesia using a syringe pump, followed by intravenous infusion of saline with the same volume until 30 minutes before the end of the surgery (when the skin is being sutured by the surgeon) using syringe pump.
Treatment:
Drug: Lidocaine IV

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems